Evidence map›Paper›PMID 40844417›Full record

ArticleJournal of neurotrauma2025

STARSHIP Part 2: Disturbed Pressure Reactivity Duration and Magnitude in Pediatric Severe Traumatic Brain Injury-Outcome Implications.

Claudia Ann Smith, Stefan Yu Bögli, Michał Placek, Manuel Cabeleira, Deborah White, Esther Daubney, Adam Young, Erta Beqiri, Riaz Kayani, Roddy O'Donnell and 18 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of neurotrauma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Claudia Ann SmithDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0003-3643-6191
Stefan Yu BögliDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
Michał PlacekDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0001-7936-5202
Manuel CabeleiraDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
Deborah WhiteDepartment of Pediatrics, University of Cambridge, Cambridge, United Kingdom.
Esther DaubneyDepartment of Pediatrics, University of Cambridge, Cambridge, United Kingdom.
Adam YoungDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
Erta BeqiriDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
Riaz KayaniPediatric Intensive Care, Cambridge University Hospitals, Cambridge, United Kingdom.
Roddy O'DonnellPediatric Intensive Care, Cambridge University Hospitals, Cambridge, United Kingdom.
Nazima PathanDepartment of Pediatrics, University of Cambridge, Cambridge, United Kingdom.
Suzanna WatsonPediatric Neuropsychology, Cambridge and Peterborough NHS Foundation Trust, Cambridge, United Kingdom.
Anna MawDepartment of Pediatrics, University of Cambridge, Cambridge, United Kingdom.
Matthew GarnettDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
Hari Krishnan KanthimathinathanPediatric Intensive Care, Birmingham Children's Hospital, Birmingham, United Kingdom.
Harish BangalorePediatric Intensive Care, Great Ormond Street Hospital, London, United Kingdom.
Santosh SundararajanPediatric Intensive Care, Leeds Children's Hospital, Leeds, United Kingdom.
Gayathri SubramanianPediatric Intensive Care, Manchester Children's Hospital, Manchester, United Kingdom.
Dusan RaffajPediatric Intensive Care, Nottingham Children's Hospital, Nottingham, United Kingdom.
Simona LamparielloPediatric Intensive Care, Oxford University Hospitals, Oxford, United Kingdom.
Avishay SarfattiPediatric Intensive Care, Royal London Hospital, London, United Kingdom.
Anton MayerPediatric Intensive Care, Sheffield Children's Hospital, Sheffield, United Kingdom.
Oliver RossPediatric Intensive Care, Southampton General Hospital, Southampton, United Kingdom.
Marek CzosnykaDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
Peter John HutchinsonDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
Peter SmielewskiDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
Shruti AgrawalDepartment of Pediatrics, University of Cambridge, Cambridge, United Kingdom.
STARSHIP Study Team

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebral autoregulation (CA) plays a critical role in maintaining cerebral blood flow (CBF) amid fluctuations in systemic blood pressure, with dysfunction increasing vulnerability to secondary brain injury, particularly after traumatic brain injury (TBI). While extensively studied in adults, CA dynamics in pediatric TBI (pTBI) remain relatively unexplored. Studying Trends in AutoRegulation in Severe Head Injury in Pediatrics (STARSHIP), the first multicenter, prospective study on CA in pTBI, investigates the pressure reactivity index (PRx) and its association with outcomes. PRx, calculated as the Pearson's correlation between mean arterial pressure and intracranial pressure, provides insights into the patient's CA status. In this article, STARSHIP Part 2 characterizes PRx disturbances using dose metrics that take the magnitude of PRx disturbance, and the time in which the patient experiences this derangement, into consideration. We calculated the dose (overall and hourly) and percentage time spent with a PRx above thresholds 0-0.4 in 135 children with TBI. Associations with outcome were explored via summary metrics and over time, using uni- and multivariable, and ordinal regression with propensity score matching, correcting for known outcome predictors. Patients with poor outcomes exhibited higher PRx dose and percentage time above threshold, even after adjusting for clinical predictors. Time trend analyses highlighted elevated PRx metrics in poor outcome groups during the first-week post-injury. Duration of impaired pressure reactivity, as denoted by the percentage time a patient spent with a PRx >0, is robustly and independently associated with dichotomized outcome at 12 months post-ictus. Our results highlight the predictive strength of PRx metrics, with percentage time above a threshold of 0 emerging as the most robust indicator of 12-month outcome. This work supports further investigation into the feasibility and impact of interventions guided by real-time CA monitoring in severe pTBI.

Indexed as

Blood PressureBrain Injuries, TraumaticCerebrovascular CirculationHomeostasisIntracranial PressureAdolescentChildChild, PreschoolFemaleHumansMaleProspective Studiescerebral autoregulationmultimodality monitoringpediatric traumatic brain injurypressure reactivity index

Identifiers

PMID40844417
PMCPMC12505629

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.